| May 26 2023 |
China Proposes to Amend GB 4806.1 General Safety Standard for Food-Contact Materials |
Keller and Heckman LLP |
| May 26 2023 |
Analogous Art Must Be Compared to Challenged Patent |
McDermott Will & Schulte LLP |
| May 26 2023 |
Mcdermottplus Check-Up: May 26, 2023 |
McDermott Will & Schulte LLP |
| May 25 2023 |
Florida Bans Offshoring of Certain Patient Information |
Sheppard, Mullin, Richter & Hampton LLP |
| May 25 2023 |
Supreme Court Unanimously Affirms Amgen Repatha® Antibody Patents Invalid for Lack of Enablement |
Mintz |
| May 25 2023 |
Salmonella Outbreak Linked to Papa Murphy’s Cookie Dough |
Keller and Heckman LLP |
| May 25 2023 |
Minnesota Legislature Passes New Recreational Marijuana Bill |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| May 25 2023 |
EPA Will Propose Updates to New Chemicals Regulations to Improve Efficiency, Remove LVE and LoREX Exemptions for PFAS and Certain PBTs |
Bergeson & Campbell, P.C. |
| May 25 2023 |
FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities |
Nelson Mullins |
| May 25 2023 |
White House OSTP Extends Comment Period for RFI on NNI EHS Research Strategy |
Bergeson & Campbell, P.C. |
| May 24 2023 |
Implementation of FASTER Act Poses Challenge for Industry |
Keller and Heckman LLP |
| May 24 2023 |
Sequencing the Impact: How AI is Boosting Genomic Medicine |
Foley & Lardner LLP |
| May 24 2023 |
Mississippi Department of Health Revises Medical Cannabis Regulations: Feels Like I’ve Been Here Before |
Bradley Arant Boult Cummings LLP |
| May 23 2023 |
Registration Opens for NNI’s Second Webinar on U.S. Government Activities Addressing Micro- and Nanoplastic Issues |
Bergeson & Campbell, P.C. |
| May 23 2023 |
Marijuana in the Manufacturing Workplace |
Jackson Lewis P.C. |
| May 23 2023 |
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate |
Epstein Becker & Green, P.C. |
| May 22 2023 |
Supreme Court Voids Amgen’s Patents using “Undue Experimentation” Standard |
Schwegman, Lundberg & Woessner, P.A. |
| May 19 2023 |
Supreme Court Delivers the Final Blow to Amgen |
Bradley Arant Boult Cummings LLP |
| May 19 2023 |
FDA Issues Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products and Devices |
McDermott Will & Schulte LLP |
| May 18 2023 |
Blunt Rejection of Attorney Fees in Stipulated Dismissal |
McDermott Will & Schulte LLP |
| May 18 2023 |
Supreme Court Upholds California Proposition 12, Protecting Worker Safety and Animal Welfare |
Tycko & Zavareei LLP |
| May 18 2023 |
Uncertainty for the North Carolina Pork Industry: US Supreme Court Upholds California's Proposition 12 |
Ward and Smith, P.A. |
| May 18 2023 |
FDA Releases Draft Compliance Policy Guide on Major Food Allergen Labeling and Cross-Contact |
Keller and Heckman LLP |
| May 18 2023 |
California Assembly Passes Ban on Chemicals in Processed Food |
Keller and Heckman LLP |
| May 18 2023 |
Third Party Administrator and Pharmacy Benefit Manager Licensing and Compliance Developments |
Polsinelli PC |
| May 18 2023 |
U.S. Executive Branch Update – May 18, 2023 |
Squire Patton Boggs (US) LLP |
| May 18 2023 |
Weeded Out: Drug Paraphernalia Mark Described as “Essential Oil Dispenser” Refused Registration |
McDermott Will & Schulte LLP |
| May 18 2023 |
FDA and SAMHSA Issue Joint Statement in Support of Reducing Barriers to Evidence Based Treatments |
Foley & Lardner LLP |
| May 17 2023 |
Defense Victory in Mislabeling Lawsuit Affirmed on Preemption Grounds |
Keller and Heckman LLP |
| May 17 2023 |
Supreme Court Narrows Dormant Commerce Clause Protections Against Regulation of Business in Decision Affirming California Pork Law |
Beveridge & Diamond PC |
| May 17 2023 |
PERSON VERSUS ENTITY: Where you fall in the definition matters with CIPA |
Troutman Amin, LLP |
| May 16 2023 |
Supreme Court Won’t Hear Skinny Label Case |
Foley & Lardner LLP |
| May 16 2023 |
Software as a Medical Device: Challenges Facing the Industry |
Foley & Lardner LLP |
| May 16 2023 |
Federal Circuit Considers Patentability of Overlapping Ranges |
Foley & Lardner LLP |
| May 16 2023 |
Public Nuisance Claims: Altria’s Vaping Trial Highlights Potential Expansion |
Foley & Lardner LLP |
